AVNS - CIK 0001606498
The table below shows AVANOS MEDICAL, INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $74.70M | $100.70M | $32.40M | $90.90M | $87.30M | -$2.50M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$60.60M | -$27.50M | $21.60M | -$135.40M | -$21.00M | -$24.20M |
| Dividends paid | - | - | - | - | - | - |
AVANOS MEDICAL, INC. reported operating cash flow of $74.70M for fiscal year 2025. That is down 25.8% from $100.70M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from $188.80M (FY 2016) to $74.70M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $3.30M | $12.80M | $19.10M | $45.50M | $11.50M | $900.00K |
| Financing cash flow | -$37.00M | -$49.10M | -$94.20M | $56.70M | -$55.30M | -$70.00M |